Skip to content

The Effect of Virtual Reality Application on Pain Due to Fistula Puncture in Hemodialysis Patients

The Effect of Virtual Reality Application on Fistula Puncture Associated Pain in Hemodialysis Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05807906
Enrollment
14
Registered
2023-04-11
Start date
2023-04-17
Completion date
2023-05-31
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases

Brief summary

The aim of this study is to examine the effect of virtual reality application on fistula puncture-related pain (FPi-A) in hemodialysis patients. Hypotheses of the Research: H0-1: Virtual reality application has an effect on fistula puncture-related pain in HD patients. H1-2: Virtual reality application has no effect on fistula puncture-related pain in HD patients. In the study, virtual reality will be applied in the fistula puncture procedure in patients receiving hemodialysis treatment.

Detailed description

* Demographic/medical data will initially be recorded prior to fistula puncture. * The patient will be prepared for the virtual reality application and fistula puncture and will be given a comfortable sitting position. * Virtual reality glasses will be put on the patient 6 minutes before the fistula puncture and the application will be started. * The patient will continue to monitor the virtual reality application during the fistula puncture procedure. It will be ensured that no communication with the patient is made until the application is finished. * The application will be ended with the fixation of the needle on the fistula after the fistula puncture procedure.

Interventions

The patient will continue to monitor the virtual reality application during the fistula puncture procedure.

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* No diagnosis of neuropathic pain * No sedatives, analgesics and sedatives are applied 3 hours before the application. * Not taking recently taken antipsychotic drugs and tranquilizers, * Deaf and visually impaired (to mark VAS pain) * Without cognitive and psychiatric diagnosis * Open to communication and cooperation * Patients who agreed to participate in the study

Exclusion criteria

* Kidney transplant * Discomfort due to virtual reality glasses * Suspected/diagnosed COVID-19 * Patients who want to leave the study voluntarily * Death * Multiple fistula puncture attempts

Design outcomes

Primary

MeasureTime frameDescription
Pain-VAS ScaleAssessing change of pain scores baseline, after each application for three weeks. Between third and fifth weeks any intervention will not be implemented and pain scale score will measure fifth week.VAS Scale is scored from 1 to 10. As the score increases, the severity of pain increases.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026